The impact of bubbles on measurement of drug release from echogenic liposomes

Ultrasonics Sonochemistry

Volumn 20, Issue 4, 2013, Pages 1121-1130

  Kopechek, Jonathan A ^a   Haworth, Kevin J ^a,b   Radhakrishnan, Kirthi ^a   Huang, Shao Ling ^c   Klegerman, Melvin E ^c   McPherson, David D ^c   Holland, Christy K ^a,b  

^a University of Cincinnati   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cavitation; Drug release; Echogenic liposomes; Pulsed Doppler ultrasound; Rosiglitazone; Spectrofluorometric techniques

Indexed keywords

BUBBLES (IN FLUIDS); CAVITATION; FLUORESCENCE; LIPOSOMES; NON NEWTONIAN FLOW; TARGETED DRUG DELIVERY; ULTRASONIC APPLICATIONS;

DRUG RELEASE; ECHOGENIC LIPOSOMES; PULSED DOPPLER; ROSIGLITAZONE; SPECTROFLUOROMETRIC TECHNIQUES;

CONTROLLED DRUG DELIVERY;

CALCEIN; ECHOGENIC LIPOSOME; LIPOSOME; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FLUORESCENCE ANALYSIS; MOLECULAR INTERACTION; PRESSURE; PRIORITY JOURNAL; ULTRASOUND SCANNER;

EID: 84874942926     PISSN: 13504177     EISSN: 18732828     Source Type: Journal    
DOI: 10.1016/j.ultsonch.2012.12.005     Document Type: Article

References (60)

1. AHA, Heart Disease and Stroke Statistics - 2013, Circulation, 127 (2013) e6-e245.
2. C.D. Lee, A.R. Folsom, F.J. Nieto, L.E. Chambless, E. Shahar, and D.A. Wolfe White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study Am. J. Epidemiol. 154 2001 758 764
3. N. Marx, G. Sukhova, C. Murphy, P. Libby, and J. Plutzky Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro Am. J. Pathol. 153 1998 17 23
4. A.C. Li, C.J. Binder, A. Gutierrez, K.K. Brown, C.R. Plotkin, J.W. Pattison, A.F. Valledor, R.A. Davis, T.M. Willson, J.L. Witztum, W. Palinski, and C.K. Glass Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma J. Clin. Invest. 114 2004 1564 1576
5. A. Pucci, L. Formato, M. Muscio, E. Brscic, S. Pizzimenti, F. Ferroni, M. Ribezzo, C. Toaldo, P. Pettazzoni, E. Ciamporcero, G. Barrera, M. Rinaldi, L. Bergamasco, I. Sheiban, and M.T. Spinnler PPARgamma in coronary atherosclerosis: in vivo expression pattern and correlations with hyperlipidemic status and statin treatment Atherosclerosis 218 2011 479 485
6. A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, and C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J. Clin. Invest. 106 2000 523 531
7. A.C. Calkin, J.M. Forbes, C.M. Smith, M. Lassila, M.E. Cooper, K.A. Jandeleit-Dahm, and T.J. Allen Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects Arterioscler. Thromb. Vasc. Biol. 25 2005 1903 1909
8. S. Zhao, C. Zhang, Y. Lin, P. Yang, Q. Yu, Y. Chu, P. Yang, J. Fan, and E. Liu The effects of rosiglitazone on aortic atherosclerosis of cholesterol-fed rabbits Thromb. Res. 123 2008 281 287
9. S. Singh, Y.K. Loke, and C.D. Furberg Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis JAMA 298 2007 1189 1195
10. S.E. Nissen, and K. Wolski Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N. Engl. J. Med. 356 2007 2457 2471
11. S.L. Huang Liposomes in ultrasonic drug and gene delivery Adv. Drug Deliv. Rev. 60 2008 1167 1176
12. H. Alkan-Onyuksel, S.M. Demos, G.M. Lanza, M.J. Vonesh, M.E. Klegerman, B.J. Kane, J. Kuszak, and D.D. McPherson Development of inherently echogenic liposomes as an ultrasonic contrast agent J. Pharm. Sci. 85 1996 486 490
13. S.M. Herbst, M.E. Klegerman, H. Kim, J. Qi, H. Shelat, M. Wassler, M.R. Moody, C.M. Yang, X. Ge, Y. Zou, J.A. Kopechek, F.J. Clubb, D.C. Kraemer, S. Huang, C.K. Holland, D.D. McPherson, and Y.J. Geng Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1 Mol. Pharm. 7 2010 3 11
14. H. Kim, M.R. Moody, S.T. Laing, P.H. Kee, S.L. Huang, M.E. Klegerman, and D.D. McPherson In vivo volumetric intravascular ultrasound visualization of early/inflammatory arterial atheroma using targeted echogenic immunoliposomes Invest. Radiol. 45 2010 685 691
15. J.A. Kopechek, K.J. Haworth, J.L. Raymond, T. Douglas Mast, S.R. Perrin, M.E. Klegerman, S. Huang, T.M. Porter, D.D. McPherson, and C.K. Holland Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter J. Acoust. Soc. Am. 130 2011 3472 3481
16. S.D. Tiukinhoy-Laing, K. Buchanan, D. Parikh, S. Huang, R.C. MacDonald, D.D. McPherson, and M.E. Klegerman Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes J. Drug Target. 15 2007 109 114
17. P.H. Kee, T.A. Abruzzo, D.A. Smith, J.A. Kopechek, B. Wang, S.L. Huang, R.C. MacDonald, C.K. Holland, and D.D. McPherson Synthesis, acoustic stability, and pharmacologic activities of papaverine-loaded echogenic liposomes for ultrasound controlled drug delivery J. Liposome Res. 18 2008 263 277
18. K.D. Buchanan, S.L. Huang, H. Kim, D.D. McPherson, and R.C. MacDonald Encapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered release J. Control. Release 141 2010 193 198
19. G.J. Shaw, J.M. Meunier, S.L. Huang, C.J. Lindsell, D.D. McPherson, and C.K. Holland Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes Thromb. Res. 124 2009 306 310
20. D.A. Smith, S.S. Vaidya, J.A. Kopechek, S.L. Huang, M.E. Klegerman, D.D. McPherson, and C.K. Holland Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes Ultrasound Med. Biol. 36 2010 145 157
21. S.D. Tiukinhoy-Laing, S. Huang, M. Klegerman, C.K. Holland, and D.D. McPherson Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes Thromb. Res. 119 2007 777 784
22. J.A. Kopechek, T.M. Abruzzo, B. Wang, S.M. Chrzanowski, D.A. Smith, P.H. Kee, S. Huang, J.H. Collier, D.D. McPherson, and C.K. Holland Ultrasound-mediated release of hydrophilic and lipophilic agents from echogenic liposomes J. Ultrasound Med. 27 2008 1597 1606
23. G.A. Husseini, M.A. Diaz de la Rosa, E.S. Richardson, D.A. Christensen, and W.G. Pitt The role of cavitation in acoustically activated drug delivery J. Control. Release 107 2005 253 261
24. L. Somaglino, G. Bouchoux, J.L. Mestas, and C. Lafon Validation of an acoustic cavitation dose with hydroxyl radical production generated by inertial cavitation in pulsed mode: application to in vitro drug release from liposomes Ultrason. Sonochem. 18 2011 577 588
25. T.J. Evjen, E.A. Nilssen, R.A. Fowler, S. Rognvaldsson, M. Brandl, and S.L. Fossheim Lipid membrane composition influences drug release from dioleoylphosphatidylethanolamine-based liposomes on exposure to ultrasound Int. J. Pharm. 406 2011 114 116
26. C.K. Holland, and R.E. Apfel An improved theory for the prediction of microcavitation thresholds IEEE Trans. Ultrason. Ferroelectr. Freq. Control 36 1989 204 208
27. R.E. Apfel, and C.K. Holland Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound Ultrasound Med. Biol. 17 1991 179 185
28. E.A. Neppiras Subharmonic and other low-frequency emission from bubbles in sound-irradiated liquids J. Acoust. Soc.Am. 46 1969 587 601
29. C.K. Holland, and R.E. Apfel Thresholds for transient cavitation produced by pulsed ultrasound in a controlled nuclei environment J. Acoust. Soc. Am. 88 1990 2059 2069
30. A. Eller, and H.G. Flynn Generation of subharmonics of order one-half by bubbles in a sound field J. Acoust. Soc.Am. 44 1968 368 369
31. D.M. Hallow, A.D. Mahajan, T.E. McCutchen, and M.R. Prausnitz Measurement and correlation of acoustic cavitation with cellular bioeffects Ultrasound Med. Biol. 32 2006 1111 1122
32. J. Collis, R. Manasseh, P. Liovic, P. Tho, A. Ooi, K. Petkovic-Duran, and Y. Zhu Cavitation microstreaming and stress fields created by microbubbles Ultrasonics 50 2010 273 279
33. C.K. Holland, C.X. Deng, R.E. Apfel, J.L. Alderman, L.A. Fernandez, and K.J. Taylor Direct evidence of cavitation in vivo from diagnostic ultrasound Ultrasound Med. Biol. 22 1996 917 925
34. D.L. Miller, M.A. Averkiou, A.A. Brayman, E.C. Everbach, C.K. Holland, J.H. Wible Jr., and J. Wu Bioeffects considerations for diagnostic ultrasound contrast agents J. Ultrasound Med. 27 2008 611 632 Quiz 633-636
35. W.L. Nyborg Acoustic streaming near a boundary J. Acoust. Soc.Am. 30 1958 329 339
36. P. Prentice, A. Cuschieri, K. Dholakia, M. Prausnitz, and P. Campbell Membrane disruption by optically controlled microbubble cavitation Nature Phys. Lett. 1 2005 107 110
37. P. Zhong, and C.J. Chuong Propagation of shock waves in elastic solids caused by cavitation microjet impact. I: theoretical formulation J. Acoust. Soc. Am. 94 1993 19 28
38. S. Datta, C.C. Coussios, A.Y. Ammi, T.D. Mast, G.M. de Courten-Myers, and C.K. Holland Ultrasound-enhanced thrombolysis using definity as a cavitation nucleation agent Ultrasound Med. Biol. 34 2008 1421 1433
39. S. Datta, C.C. Coussios, L.E. McAdory, J. Tan, T. Porter, G. De Courten-Myers, and C.K. Holland Correlation of cavitation with ultrasound enhancement of thrombolysis Ultrasound Med. Biol. 32 2006 1257 1267
40. N. McDannold, N. Vykhodtseva, and K. Hynynen Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity Phys. Med. Biol. 51 2006 793 807
41. Y.S. Tung, F. Vlachos, J.J. Choi, T. Deffieux, K. Selert, and E.E. Konofagou In vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in mice Phys. Med. Biol. 55 2010 6141 6155
42. D. Chen, and J. Wu An in vitro feasibility study of controlled drug release from encapsulated nanometer liposomes using high intensity focused ultrasound Ultrasonics 50 2010 744 749
43. Y. Qiu, Y. Luo, Y. Zhang, W. Cui, D. Zhang, J. Wu, J. Zhang, and J. Tu The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro J. Control. Release 145 2010 40 48
44. Y. Zhou, J. Cui, and C.X. Deng Dynamics of sonoporation correlated with acoustic cavitation activities Biophys. J. 94 2008 L51 L53
45. D.A. Kendall, and R.C. MacDonald Characterization of a fluorescence assay to monitor changes in the aqueous volume of lipid vesicles Anal. Biochem. 134 1983 26 33
46. A. Memoli, L.G. Palermiti, V. Travagli, and F. Alhaique Effects of surfactants on the spectral behaviour of calcein (II): a method of evaluation J. Pharm. Biomed. Anal. 19 1999 627 632
47. H.Y. Lin, and J.L. Thomas Factors affecting responsivity of unilamellar liposomes to 20 kHz ultrasound Langmuir 20 2004 6100 6106
48. A.L. Klibanov, T.I. Shevchenko, B.I. Raju, R. Seip, and C.T. Chin Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery J. Control. Release 148 2010 13 17
49. S.L. Huang, D.D. McPherson, and R.C. Macdonald A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery Ultrasound Med. Biol. 34 2008 1272 1280
50. S.L. Huang, and R.C. MacDonald Acoustically active liposomes for drug encapsulation and ultrasound-triggered release Biochim. Biophys. Acta 1665 2004 134 141
51. K.D. Buchanan, S. Huang, H. Kim, R.C. Macdonald, and D.D. McPherson Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature J. Pharm. Sci. 97 2008 2242 2249
52. S.L. Huang, A.J. Hamilton, E. Pozharski, A. Nagaraj, M.E. Klegerman, D.D. McPherson, and R.C. MacDonald Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents Ultrasound Med. Biol. 28 2002 339 348
53. S.L. Huang, A.J. Hamilton, A. Nagaraj, S.D. Tiukinhoy, M.E. Klegerman, D.D. McPherson, and R.C. Macdonald Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents J. Pharm. Sci. 90 2001 1917 1926
54. S. Huang, P. Kee, D.D. McPherson, and R.C. Macdanold Multi-functional echogenic liposomes for image-guided ultrasound-controlled PPAR agonist delivery J. Am. Coll. Cardiol. 49 Suppl 1 2007 365A
55. C.C. Coussios, C.K. Holland, L. Jakubowska, S.L. Huang, R.C. MacDonald, A. Nagaraj, and D.D. McPherson In vitro characterization of liposomes and Optison by acoustic scattering at 3.5 MHz Ultrasound Med. Biol. 30 2004 181 190
56. A. Schroeder, Y. Avnir, S. Weisman, Y. Najajreh, A. Gabizon, Y. Talmon, J. Kost, and Y. Barenholz Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility Langmuir 23 2007 4019 4025
57. J. Park, Z. Fan, and C.X. Deng Effects of shear stress cultivation on cell membrane disruption and intracellular calcium concentration in sonoporation of endothelial cells J. Biomech. 44 2011 164 169
58. T.J. Evjen, E.A. Nilssen, S. Rognvaldsson, M. Brandl, and S.L. Fossheim Distearoylphosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery Eur. J. Pharm. Biopharm. 75 2010 327 333
59. K.E. Hitchcock, D.N. Caudell, J.T. Sutton, M.E. Klegerman, D. Vela, G.J. Pyne-Geithman, T. Abruzzo, P.E. Cyr, Y.J. Geng, D.D. McPherson, and C.K. Holland Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model J. Control. Release 144 2010 288 295
60. S.T. Laing, H. Kim, J.A. Kopechek, D. Parikh, S. Huang, M.E. Klegerman, C.K. Holland, and D.D. McPherson Ultrasound-mediated delivery of echogenic immunoliposomes to porcine vascular smooth muscle cells in vivo J. Liposome Res. 20 2010 160 167